Ultrastructural markers of quality in human mature oocytes vitrified using cryoleaf and cryoloop

Reprod Biomed Online. 2009:19 Suppl 3:17-27. doi: 10.1016/s1472-6483(10)60280-5.

Abstract

This study describes and compares the possible effects of vitrification on the ultrastructural morphology of 20 human mature oocytes vitrified using two different supports, cryoleaf (n = 10) and cryoloop (n = 10). Fresh human mature oocytes (n = 15) were used as controls. Fresh and vitrified-warmed oocytes appeared rounded, with a homogeneous cytoplasm, an intact oolemma and a continuous zona pellucida. Sparse microvacuolization was only occasionally detected in fresh and vitrified-warmed oocytes, to the same extent. About 50% of the vitrified oocytes contained atypical, small and slender mitochondria-smooth endoplasmic reticulum aggregates, whereas a non-homogeneous microvillar pattern was observable in only 30% of the oocytes subjected to vitrification, regardless of the support utilized. Cortical granule content appeared generally reduced after vitrification, but cryoleaf-supported oocytes contained more cortical granules than cryoloop-supported oocytes (P < 0.05). Thus good overall preservation and virtual absence of cytoplasmic vacuolization seem to be the most relevant markers of quality in vitrified-warmed oocytes, using either support. In addition, cryoleaf-supported oocytes retained a higher number of cortical granules than cryoloop-supported oocytes. The variety of ultrastructural alterations recorded emphasizes the need for further studies aimed at assessing the actual tolerance of human oocytes to vitrification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Cell Membrane / drug effects
  • Cell Membrane / ultrastructure*
  • Cryopreservation / methods*
  • Cryoprotective Agents / pharmacology
  • Freezing
  • Humans
  • Microscopy, Electron, Transmission
  • Oocytes / drug effects
  • Oocytes / ultrastructure*
  • Vacuoles / drug effects
  • Vacuoles / ultrastructure*
  • Zona Pellucida / drug effects
  • Zona Pellucida / ultrastructure

Substances

  • Biomarkers
  • Cryoprotective Agents